Claudia La Mantia
Palermo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
PHENO-RAG: An artificial intelligence tool for guideline-informed management decisions in hepatocellular carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: July 22, 2025
A Markov Model Unveiling the Impact of Resmetirom on the Natural History of MASLD Patients: A Sistematic Review and Meta-Analysis.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 13, 2024
Clinical outcomes of MAFLD versus NAFLD: A meta-analysis of observational studies.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 03, 2024
Are we ready for genetic testing in metabolic dysfunction-associated steatotic liver disease?
Journal: United European gastroenterology journal
Published: November 03, 2023
Curcumin and Andrographolide Co-Administration Safely Prevent Steatosis Induction and ROS Production in HepG2 Cell Line.
Journal: Molecules (Basel, Switzerland)
Published: December 29, 2022
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease.
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease.
Journal: JHEP reports : innovation in hepatology
Published: December 19, 2022
The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints.
Journal: Biomedicines
Published: September 16, 2022
MAFLD: a multisystem disease.
Journal: Therapeutic advances in endocrinology and metabolism
Published: August 01, 2022
Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: June 03, 2022
Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development.
Journal: Frontiers in immunology
Published: April 22, 2022
AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: March 28, 2022
Hepatitis C: Standard of Treatment and What to Do for Global Elimination.
Journal: Viruses
Published: January 05, 2022
Last Updated: 09/26/2026